Steinemann D, Arning L, Praulich I, Stuhrmann M, Hasle H, Starý J, Schlegelberger B, Niemeyer CM, Flotho C. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. Haematologica [Internet]. 2010Feb.5 [cited 2026Nov.13];95(2):320-3. Available from: https://haematologica.org/article/view/5504